Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Trevi Therapeutics
- Study ID
- NCT07671911
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Idiopathic Pulmonary Fibrosis
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- NAL ER — DRUGOral tablets
- Placebo — DRUGOral tablets
Study Details
The primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with Idiopathic Pulmonary Fibrosis (IPF).
Key Dates
- First listed
- Jun 26, 2026
- Start date
- Jun 29, 2026
- Status verified
- Sep 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 306 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: NAL ER 54 mgParticipants will undergo a 2-week blinded titration period (twice daily \[BID\] dosing with one NAL ER once daily \[QD\] dose and one placebo QD dose) followed by a fixed dose treatment period receiving NAL ER 54 milligrams (mg) BID for 52 weeks.
- Placebo Comparator: PlaceboParticipants will undergo a 2-week blinded titration period followed by a fixed dose treatment period receiving a matching placebo BID for 52 weeks.
Primary Outcome Measure
Relative Change from Baseline in 24-hour Cough Frequency at Week 26 [ Time Frame: Baseline, Week 26 ]
Central Contacts
- Paula Buckley(203) 304-2499
Locations (19)
Find similar trials in Newport Beach, CA
By research site
Newportnativemd, Inc.· Newport Beach, CAPalmtree Clinical Research· Palm Springs, CAParadigm Clinical Research Centers, Inc. - Redding· Redding, CACritical Care Pulmonary and Sleep Associates (Ccpsa) - West Clinic· Lakewood, COMeris Clinical Research· Brandon, FLClinical Research Specialists, Llc - Kissimmee· Kissimmee, FL
Related Studies
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailurePHASE1/PHASE2 · Recruiting · Paul Szabolcs · Pittsburgh, Pennsylvania
- University of Virginia Natural History StudyEnrolling By Invitation · University of Virginia · Charlottesville, Virginia
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseasePHASE3 · Enrolling By Invitation · United Therapeutics · Birmingham, Alabama